黑丝袜的诱惑韩国 , Inc. is pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Our initial focus is on the treatment of heritable cardiomyopathies, a group of rare, genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction.
June 24, 2019
黑丝袜的诱惑韩国 Publishes Data in Nature Digital Medicine Showing Potential of Wrist-Worn Biosensor to Screen for Hypertrophic Cardiomyopathy
May 28, 2019
黑丝袜的诱惑韩国 Presents Results from Phase 1a Clinical Trial of MYK-491 at the European Society of Cardiology Heart Failure Congress
May 9, 2019
黑丝袜的诱惑韩国 Reports First Quarter 2019 Financial Results